Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Maria del Mar Gutierrez, Mª Gracia Mateo, Noemí Corbacho, Francesc Vidal & Pere Domingo. (2019) Drug-drug interactions when treating HIV-related metabolic disorders. Expert Opinion on Drug Metabolism & Toxicology 15:10, pages 787-802.
Read now
Read now
Pierre Delanaye & André J. Scheen. (2019) Preventing and treating kidney disease in patients with type 2 diabetes. Expert Opinion on Pharmacotherapy 20:3, pages 277-294.
Read now
Read now
Tomoyuki Kawada. (2019) Sodium-glucose co-transporter 2 inhibitors and serum uric acid. Current Medical Research and Opinion 35:2, pages 179-180.
Read now
Read now
T. Min, L. Wali, D.M. Williams, E. Plummer, A. Gurung & J.W. Stephens. (2017) Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551. Current Medical Research and Opinion 33:9, pages 1715-1716.
Read now
Read now
Articles from other publishers (14)
Bahador Bagheri, Habib Yaribeygi, Erfan Taherifard, Azita Hajhossein Talasaz, Haleh Bagheri, Mahboubeh Darban, Reza Tabrizi, Siamak Najafi, Mahmoud Khodadost & Maryam Akbari. (2022) Sodium‐glucose cotransporter 2 inhibitors: A comprehensive review from cells to bedside. Fundamental & Clinical Pharmacology 37:3, pages 481-492.
Crossref
Crossref
Mitchell H. Rosner, Nam Ha, Biff F. Palmer & Mark A. Perazella. (2023) Acquired Disorders of Hypomagnesemia. Mayo Clinic Proceedings 98:4, pages 581-596.
Crossref
Crossref
Michael K. Danquah & Jaison Jeevanandam. 2022. Emerging Nanomedicines for Diabetes Mellitus Theranostics. Emerging Nanomedicines for Diabetes Mellitus Theranostics
1
31
.
Reem Y Alhassani, Reem M Bagadood, Rafal N Balubaid, Haneen I Barno, Mariah O Alahmadi & Nahla A Ayoub. (2021) Drug Therapies Affecting Renal Function: An Overview. Cureus.
Crossref
Crossref
Denise Coutinho de Miranda, Gabriela de Oliveira Faria, Milla Marques Hermidorff, Fernanda Cacilda dos Santos Silva, Leonardo Vinícius Monteiro de Assis & Mauro César Isoldi. (2021) Pre- and Post-Conditioning of the Heart: An Overview of Cardioprotective Signaling Pathways. Current Vascular Pharmacology 19:5, pages 499-524.
Crossref
Crossref
Habib Yaribeygi, Luis E. Simental-Mendía, Maciej Banach, Simona Bo & Amirhossein Sahebkar. (2019) The major molecular mechanisms mediating the renoprotective effects of SGLT2 inhibitors: An update. Biomedicine & Pharmacotherapy 120, pages 109526.
Crossref
Crossref
Yi-Hsuan Lin, Yu-Yao Huang, Sheng-Hwu Hsieh, Jui-Hung Sun, Szu-Tah Chen & Chia-Hung Lin. (2019) Renal and Glucose-Lowering Effects of Empagliflozin and Dapagliflozin in Different Chronic Kidney Disease Stages. Frontiers in Endocrinology 10.
Crossref
Crossref
Blythe D. Shepard. (2019) Sex differences in diabetes and kidney disease: mechanisms and consequences. American Journal of Physiology-Renal Physiology 317:2, pages F456-F462.
Crossref
Crossref
Dario Giugliano, Luca De Nicola, Maria Ida Maiorino, Giuseppe Bellastella & Katherine Esposito. (2019) Type 2 diabetes and the kidney: Insights from cardiovascular outcome trials. Diabetes, Obesity and Metabolism 21:8, pages 1790-1800.
Crossref
Crossref
Habib Yaribeygi, Stephen L. Atkin, Niki Katsiki & Amirhossein Sahebkar. (2018) Narrative review of the effects of antidiabetic drugs on albuminuria. Journal of Cellular Physiology 234:5, pages 5786-5797.
Crossref
Crossref
A.J. Scheen. (2019) Effects of glucose-lowering agents on surrogate endpoints and hard clinical renal outcomes in patients with type 2 diabetes. Diabetes & Metabolism 45:2, pages 110-121.
Crossref
Crossref
Paula Nogueira da Silva, Raissa Alves da Conceição, Rodolfo do Couto Maia & Maria Leticia de Castro Barbosa. (2018) Sodium–glucose cotransporter 2 (SGLT-2) inhibitors: a new antidiabetic drug class. MedChemComm 9:8, pages 1273-1281.
Crossref
Crossref
T.D. Filippatos, V. Tsimihodimos, G. Liamis & M.S. Elisaf. (2018) SGLT2 inhibitors-induced electrolyte abnormalities: An analysis of the associated mechanisms. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12:1, pages 59-63.
Crossref
Crossref
Xiaoxin X. Wang, Jonathan Levi, Yuhuan Luo, Komuraiah Myakala, Michal Herman-Edelstein, Liru Qiu, Dong Wang, Yingqiong Peng, Almut Grenz, Scott Lucia, Evgenia Dobrinskikh, Vivette D. D'Agati, Hermann Koepsell, Jeffrey B. Kopp, Avi Z. Rosenberg & Moshe Levi. (2017) SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy. Journal of Biological Chemistry 292:13, pages 5335-5348.
Crossref
Crossref